Interest of the radiotherapy-hormonotherapy association in the treatment of the high-risk prostate cancer

被引：1
|
作者：
Bolla, M. [1 ]
Fourneret, P. [1 ]
Descotes, J. -L. [2 ]
机构：
[1] CHU, Clin Univ Cancerol Radiotherapie, F-63011 Grenoble, France
[2] CHU, Clin Univ Urol, F-63011 Grenoble, France
来源：
BULLETIN DU CANCER | 2008年 / 95卷 / 12期
关键词：
high-risk prostate cancer; combination of external irradiation and androgen suppression;
D O I：
10.1684/bdc.2008.0755
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Treatment of high-risk prostate cancer-localized or locally advanced-is based on the combination of external irradiation and hormonal treatment by LHRH analogue (aLHRH) according to the results of phases III randomized trials RTOG and/or EORTC trials. These trials show a significant improvement of overall or specific survival. Localized prostate cancer require 6-month complete androgen blockade, while locally advanced prostate cancer need a long-term hormonal treatment for a duration ranging from 2,5 to 3 years. Some trials, which have a long follow-up show that the risk of cardiovascular death is not significantly increased by hormonal treatment.
引用
收藏
页码：1213 / 1218
页数：6
相关论文
共 50 条
  • [1] Association of radiotherapy and hormonotherapy in locally advanced prostate cancer
    Quero, Laurent
    Wong-Hee-Kam, Stephanie
    Rivera, Sofia
    Hennequin, Christophe
    BULLETIN DU CANCER, 2012, 99 : S30 - S36
  • [2] Radiotherapy for high-risk prostate cancer
    Jahan J. Mohiuddin
    Brock R. Baker
    Ronald C. Chen
    Nature Reviews Urology, 2015, 12 : 145 - 154
  • [3] Radiotherapy for high-risk prostate cancer
    Mohiuddin, Jahan J.
    Baker, Brock R.
    Chen, Ronald C.
    NATURE REVIEWS UROLOGY, 2015, 12 (03) : 145 - 154
  • [4] Postoperative radiotherapy for high-risk prostate cancer
    Haines, Ian
    LANCET, 2013, 381 (9872): : 1093 - 1093
  • [5] Postprostatectomy radiotherapy for high-risk prostate cancer
    Mayer, R
    Pummer, K
    Quehenberger, F
    Mayer, E
    Fink, L
    Hackl, A
    UROLOGY, 2002, 59 (05) : 732 - 739
  • [6] Management of high-risk prostate cancer: surgery or radiotherapy with hormonal treatment
    Soulie, M.
    Richaud, P.
    ONCOLOGIE, 2012, 14 (02) : 79 - 86
  • [7] Pelvic proton radiotherapy for high-risk prostate cancer
    Chera, B. S.
    Vargas, C.
    Flampouri, S.
    Morris, C. G.
    Yeung, D.
    Olivier, K.
    Duvvuri, S.
    Li, Z.
    Mendenhall, N. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S326 - S326
  • [8] Use and timing of radiotherapy in high-risk prostate cancer
    Ward, JF
    Blute, ML
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (23): : 2817 - 2817
  • [9] Radiotherapy after prostatectomy in high-risk prostate cancer
    Roviello, G.
    Villari, D.
    Nesi, G.
    Detti, B.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (11): : 2139 - 2140
  • [10] Comparative efficacy of radical prostatectomy and radiotherapy in the treatment of high-risk prostate cancer
    Yu, Lu
    Yan, Ruping
    Yang, Deling
    Xia, Chengxing
    Zhang, Zhixian
    TECHNOLOGY AND HEALTH CARE, 2024, 32 (06) : 4671 - 4679
12345